Amsterdam: Dutch medical device manufacturer Phillips i said that on tuesday independent testing showed 95 percent respiratory involved in Massive global recall showed a limited health risk. The company expects test results of the remaining machines involved in the recall to be available later this year.
Amsterdam location Phillips Addressing the impact of a global recall of millions of ventilators used in care sleep apnea syndrome Since it was announced in June 2021, citing concerns that the foam used in the machine could be toxic.
The company said exposure to particulate matter and volatile organic compounds emitted from the degraded foam of the DreamStation equipment is “unlikely to cause significant harm to patient health.”
Philips had already said last year that tests showed that foam degradation was very rare and linked to the use of unapproved ozone-based cleaning products.
It is now added that foam degradation as a result of such cleaning is also unlikely to pose significant harm.